胃食管-话题@MedSci

#胃食管#

153篇内容 | 2960人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1948613, encodeId=1e681948613c5, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=Cancers：晚期胃食管癌免疫疗法的生物标志物, objectType=article, longId=211939, objectId=cad621193990, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cad621193990, replyNumber=0, likeNumber=62, createdTime=2021-06-25, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cad621193990, moduleTitle=Cancers：晚期胃食管癌免疫疗法的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cad621193990)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948614, encodeId=d9c3194861447, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=Lancet：纳武单抗+化疗用于晚期胃食管腺癌的疗效显著优于单纯化疗, objectType=article, longId=212478, objectId=90e32124e8db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90e32124e8db, replyNumber=0, likeNumber=66, createdTime=2022-04-26, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90e32124e8db, moduleTitle=Lancet：纳武单抗+化疗用于晚期胃食管腺癌的疗效显著优于单纯化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90e32124e8db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948604, encodeId=933d1948604a5, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=JAMA子刊：5个日常小习惯，显著减轻胃食管反流病症状, objectType=article, longId=205830, objectId=5163205830a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5163205830a2, replyNumber=0, likeNumber=100, createdTime=2021-09-09, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5163205830a2, moduleTitle=JAMA子刊：5个日常小习惯，显著减轻胃食管反流病症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5163205830a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948612, encodeId=45a4194861226, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=JAMA Oncology：降低奥沙利铂/卡培他滨化疗强度对老年或体弱晚期胃食管癌患者的生活质量和疗效评估：来自GO2 III期随机临床试验结果, objectType=article, longId=211614, objectId=6cbb211614a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cbb211614a4, replyNumber=0, likeNumber=65, createdTime=2021-11-17, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cbb211614a4, moduleTitle=JAMA Oncology：降低奥沙利铂/卡培他滨化疗强度对老年或体弱晚期胃食管癌患者的生活质量和疗效评估：来自GO2 III期随机临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cbb211614a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948618, encodeId=102c194861821, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=Eur J Cancer：胃食管癌一线治疗效果与二线治疗结果的相关性, objectType=article, longId=216405, objectId=ebbc216405c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebbc216405c0, replyNumber=0, likeNumber=66, createdTime=2021-12-02, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebbc216405c0, moduleTitle=Eur J Cancer：胃食管癌一线治疗效果与二线治疗结果的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebbc216405c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948611, encodeId=38d21948611d3, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=吃完就睡，胃食管反流风险增加12%!, objectType=article, longId=209977, objectId=75252099e718, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75252099e718, replyNumber=0, likeNumber=63, createdTime=2021-10-13, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75252099e718, moduleTitle=吃完就睡，胃食管反流风险增加12%!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75252099e718)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948610, encodeId=7b901948610cb, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=NEJM：Nivolumab辅助治疗方案用于晚期食管或胃食管交界癌患者III期临床研究获得成功, objectType=article, longId=209558, objectId=b719209558c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b719209558c2, replyNumber=0, likeNumber=72, createdTime=2021-09-20, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b719209558c2, moduleTitle=NEJM：Nivolumab辅助治疗方案用于晚期食管或胃食管交界癌患者III期临床研究获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b719209558c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948603, encodeId=6ec71948603a5, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=双特异性抗体KN026与KN046联合疗法获美国FDA孤儿药资格认定，用于治疗胃癌及胃食管连接部癌, objectType=article, longId=204839, objectId=18592048396e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18592048396e, replyNumber=0, likeNumber=122, createdTime=2021-08-26, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18592048396e, moduleTitle=双特异性抗体KN026与KN046联合疗法获美国FDA孤儿药资格认定，用于治疗胃癌及胃食管连接部癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18592048396e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948608, encodeId=8217194860809, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=J Clin Oncol：Andecaliximab联合mFOLFOX6方案作为晚期胃/胃食管交界腺癌的一线疗法的3期试验结果, objectType=article, longId=207490, objectId=06e320e49013, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06e320e49013, replyNumber=0, likeNumber=0, createdTime=2022-01-31, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06e320e49013, moduleTitle=J Clin Oncol：Andecaliximab联合mFOLFOX6方案作为晚期胃/胃食管交界腺癌的一线疗法的3期试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06e320e49013)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948602, encodeId=85491948602de, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=我国胃食管反流患者超1亿！长期不愈会增加患癌风险，你可别大意, objectType=article, longId=201275, objectId=93802012e5f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93802012e5f0, replyNumber=0, likeNumber=85, createdTime=2021-07-21, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93802012e5f0, moduleTitle=我国胃食管反流患者超1亿！长期不愈会增加患癌风险，你可别大意, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93802012e5f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948591, encodeId=e34019485917d, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=AACR 2020：季加孚教授汇报PD-1/CTLA-4双抗AK104联合化疗一线治疗晚期胃或胃食管结合部癌的Ib期研究结果, objectType=article, longId=193387, objectId=c66b19338e62, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c66b19338e62, replyNumber=0, likeNumber=79, createdTime=2020-12-13, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c66b19338e62, moduleTitle=AACR 2020：季加孚教授汇报PD-1/CTLA-4双抗AK104联合化疗一线治疗晚期胃或胃食管结合部癌的Ib期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c66b19338e62)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948597, encodeId=2a03194859ead, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=Lancet oncol：Margetuximab联合派姆单抗治疗HER2+的胃食管腺癌, objectType=article, longId=197540, objectId=9b6419e540b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b6419e540b8, replyNumber=0, likeNumber=79, createdTime=2020-07-30, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b6419e540b8, moduleTitle=Lancet oncol：Margetuximab联合派姆单抗治疗HER2+的胃食管腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b6419e540b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948601, encodeId=55dd194860111, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=欧狄沃辅助治疗食管癌及胃食管连接部癌术后患者可显著提高无病生存期, objectType=article, longId=201111, objectId=77a120111131, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77a120111131, replyNumber=0, likeNumber=83, createdTime=2020-12-26, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77a120111131, moduleTitle=欧狄沃辅助治疗食管癌及胃食管连接部癌术后患者可显著提高无病生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77a120111131)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948595, encodeId=3d5d19485959c, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=Clin Gastroenterology H:电磁括约肌增强术优于质子泵抑制剂对胃食管反流的效果, objectType=article, longId=196740, objectId=9215196e40b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9215196e40b6, replyNumber=0, likeNumber=31, createdTime=2021-03-22, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9215196e40b6, moduleTitle=Clin Gastroenterology H:电磁括约肌增强术优于质子泵抑制剂对胃食管反流的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9215196e40b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948598, encodeId=03f4194859808, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=食管癌及胃食管连接部癌术后欧狄沃（纳武利尤单抗）辅助治疗III期临床研究CheckMate -577达到主要终点无病生存期, objectType=article, longId=199310, objectId=a5e8199310d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5e8199310d0, replyNumber=0, likeNumber=71, createdTime=2021-02-23, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5e8199310d0, moduleTitle=食管癌及胃食管连接部癌术后欧狄沃（纳武利尤单抗）辅助治疗III期临床研究CheckMate -577达到主要终点无病生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5e8199310d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948594, encodeId=50051948594ca, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=Gastroenterology：胆汁酸螯合剂IW-3718辅助治疗难治性胃食管反流病, objectType=article, longId=196685, objectId=b17019668549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b17019668549, replyNumber=0, likeNumber=66, createdTime=2020-09-19, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b17019668549, moduleTitle=Gastroenterology：胆汁酸螯合剂IW-3718辅助治疗难治性胃食管反流病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b17019668549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948600, encodeId=6565194860014, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=J Gastroenterology: 在日本嗳气与胃食管反流病的患病率和相关性无关, objectType=article, longId=201045, objectId=cdfc201045d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdfc201045d7, replyNumber=0, likeNumber=0, createdTime=2021-01-27, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdfc201045d7, moduleTitle=J Gastroenterology: 在日本嗳气与胃食管反流病的患病率和相关性无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdfc201045d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948589, encodeId=6e201948589b0, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=Dig Liver Dis：慢性中性粒细胞性非过敏性鼻炎与胃食管反流病的酸暴露时间增加有关 , objectType=article, longId=191483, objectId=3ed11914837f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ed11914837f, replyNumber=0, likeNumber=60, createdTime=2020-06-24, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ed11914837f, moduleTitle=Dig Liver Dis：慢性中性粒细胞性非过敏性鼻炎与胃食管反流病的酸暴露时间增加有关 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ed11914837f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948599, encodeId=55e01948599d5, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=Clin Gastroenterology H: 饮料摄入与胃食管反流症状发生率之间的关联, objectType=article, longId=200069, objectId=fca5200069f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fca5200069f3, replyNumber=0, likeNumber=64, createdTime=2020-10-31, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fca5200069f3, moduleTitle=Clin Gastroenterology H: 饮料摄入与胃食管反流症状发生率之间的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fca5200069f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948584, encodeId=c3c91948584c9, content=<a href='/topic/show?id=87828339e7a' target=_blank style='color:#2F92EE;'>#胃食管#</a>, objectTitle=2019 ESMO ASIA |胃食管癌免疫治疗的现在和未来, objectType=article, longId=183907, objectId=3dfe18390e65, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dfe18390e65, replyNumber=0, likeNumber=68, createdTime=2020-05-08, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dfe18390e65, moduleTitle=2019 ESMO ASIA |胃食管癌免疫治疗的现在和未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dfe18390e65)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

胃食管

2020-05-29

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

Cancers：晚期胃食管癌免疫疗法的生物标志物

2021-06-25

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

Lancet：纳武单抗+化疗用于晚期胃食管腺癌的疗效显著优于单纯化疗

2022-04-26

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

JAMA子刊：5个日常小习惯，显著减轻胃食管反流病症状

2021-09-09

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

JAMA Oncology：降低奥沙利铂/卡培他滨化疗强度对老年或体弱晚期胃食管癌患者的生活质量和疗效评估：来自GO2 III期随机临床试验结果

2021-11-17

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

Eur J Cancer：胃食管癌一线治疗效果与二线治疗结果的相关性

2021-12-02

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

吃完就睡，胃食管反流风险增加12%!

2021-10-13

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

NEJM：Nivolumab辅助治疗方案用于晚期食管或胃食管交界癌患者III期临床研究获得成功

2021-09-20

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

双特异性抗体KN026与KN046联合疗法获美国FDA孤儿药资格认定，用于治疗胃癌及胃食管连接部癌

2021-08-26

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

J Clin Oncol：Andecaliximab联合mFOLFOX6方案作为晚期胃/胃食管交界腺癌的一线疗法的3期试验结果

2022-01-31

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

我国胃食管反流患者超1亿！长期不愈会增加患癌风险，你可别大意

2021-07-21

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

AACR 2020：季加孚教授汇报PD-1/CTLA-4双抗AK104联合化疗一线治疗晚期胃或胃食管结合部癌的Ib期研究结果

2020-12-13

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

Lancet oncol：Margetuximab联合派姆单抗治疗HER2+的胃食管腺癌

2020-07-30

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

欧狄沃辅助治疗食管癌及胃食管连接部癌术后患者可显著提高无病生存期

2020-12-26

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

Clin Gastroenterology H:电磁括约肌增强术优于质子泵抑制剂对胃食管反流的效果

2021-03-22

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

食管癌及胃食管连接部癌术后欧狄沃（纳武利尤单抗）辅助治疗III期临床研究CheckMate -577达到主要终点无病生存期

2021-02-23

智智灵药 (审核中...)

前往app查看评论内容

#胃食管#

Gastroenterology：胆汁酸螯合剂IW-3718辅助治疗难治性胃食管反流病

2020-09-19

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

J Gastroenterology: 在日本嗳气与胃食管反流病的患病率和相关性无关

2021-01-27

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

Dig Liver Dis：慢性中性粒细胞性非过敏性鼻炎与胃食管反流病的酸暴露时间增加有关

2020-06-24

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

Clin Gastroenterology H: 饮料摄入与胃食管反流症状发生率之间的关联

2020-10-31

循证小兵 (审核中...)

前往app查看评论内容

#胃食管#

2019 ESMO ASIA |胃食管癌免疫治疗的现在和未来

2020-05-08

科室
- - 订阅+
  - 更多科室
工具
服务